Accessibility Menu
GE HealthCare Technologies logo

GE HealthCare Technologies(NASDAQ) GEHC

Market Cap$31.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+17%
5 YearN/A
1 Year-2%
1 Month+9%
$68.26
-2.41%
-1.68Today
GE HealthCare Technologies last closing stock price
MetricPriceDate
Last closeUSD 69.942026-07-30
GE HealthCare Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+12.89%USD 61.962026-07-23
1 month+9.33%USD 63.972026-06-30
3 month+14.66%USD 61.002026-05-01
Year to date-14.6%USD 81.902025-12-31
1 year-2.19%USD 71.502025-07-30
3 year-9.87%USD 77.602023-07-31
Since inception+17.26%USD 59.642022-12-15

GE HealthCare Technologies Financials at a Glance

Market Cap

$31.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$20.24B

Net Income (TTM)

$1.59B

EPS (TTM)

$4.35

P/E Ratio

16.07

Dividend

$0.14

Beta (Volatility)

0.79 (Low)

Price

$68.26

Volume

2,656,248.282

Open

$68.84

Previous Close

$69.94

Daily Range

$67.16 - $69.02

52-Week Range

$58.75 - $89.77

Estimated Earnings Date

Nov 4, 2026

GEHC: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GE HealthCare Technologies

GE HealthCare makes medical machines and digital tools that help doctors find and treat diseases. These products allow hospitals to scan bodies, monitor heart rates, and provide safe surgery for patients. The company serves health systems and researchers in more than 160 countries.

What GE HealthCare Makes

  • Imaging: Includes CT scanners, MRIs, and X-ray systems that create detailed 3D pictures of the human body for disease detection.
  • Advanced Visualization Solutions: Focuses on specialized ultrasound systems and guidance tools used during heart procedures and surgeries.
  • Patient Care Solutions: Provides bedside monitors, anesthesia machines, and infant incubators used in operating rooms and intensive care units.
  • Pharmaceutical Diagnostics: Supplies chemicals and tracers that patients swallow or receive by injection to make organs visible during medical scans.

Recent Strategic Moves

  • Completed the spin-off from General Electric Company (now GE Aerospace) on January 3, 2023, to become an independent company.
  • Launched the Heartbeat business system to improve internal operations and focus on lean manufacturing practices.
  • Expanded digital offerings by investing in AI and cloud-based software to help clinicians manage staff shortages and patient data.

What Makes the Company Unique

The company maintains a global reach with 44 manufacturing facilities and a service team of 8,900 field engineers. This infrastructure supports a massive installed base of medical equipment that requires ongoing maintenance and software updates.

The Financial Scorecard

  • Revenue reached $4.7 billion in Q4 2025, down 12.1% from $5.3 billion in Q4 2024.
  • Gross profit rose to $2.5 billion in Q4 2025, an 11.6% increase from the previous year.
  • Net income fell to $184 million in Q4 2025, down 74.4% from $720 million in Q4 2024.
  • Free cash flow grew to $917 million in Q4 2025, up 13.1% year-over-year.

Bottom Line

GE HealthCare has transitioned from a division of a larger conglomerate to an independent specialist in medical technology and diagnostics. Its evolution focuses on combining physical hardware with digital software to improve patient outcomes globally.

AI Generated • Apr 19, 2026

Industry

Healthcare Equipment and Supplies

Employees

54,000

CEO

Peter J. Arduini

Headquarters

Chicago, IL 60661, US

GEHC Financials

Key Financial Metrics (TTM)

Gross Margin

42.90%

Operating Margin

12.70%

Net Income Margin

7.86%

Return on Equity

15.16%

Return on Capital

13.55%

Return on Assets

4.27%

Earnings Yield

6.22%

Dividend Yield

0.20%

Payout Ratio

4.02%

Stock Overview

Market Cap

$31.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

454.89M

Volume

2.66M

Avg. Volume

5.56M

Financials (TTM)

Gross Profit

$8.69B

Operating Income

$2.57B

EBITDA

$3.33B

Operating Cash Flow

$1.42B

Capital Expenditure

-$522.00M

Free Cash Flow

$895.00M

Cash & ST Invst.

$2.11B

Total Debt

$10.09B

GE HealthCare Technologies Performance Analysis

GE HealthCare Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 18,341,000,0004.3%
20232023-12-31USD 19,552,000,0006.6%
20242024-12-31USD 19,672,000,0000.6%
20252025-12-31USD 20,625,000,0004.8%
GE HealthCare Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.7%
Q42025-12-31-9.1%
Q12026-03-319.8%
Q22026-06-303.2%
GE HealthCare Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 4.22-13.9%
20232023-12-31USD 3.02-28.4%
20242024-12-31USD 4.3443.6%
20252025-12-31USD 4.554.8%
GE HealthCare Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-7.5%
Q42025-12-31-61.2%
Q12026-03-31123.7%
Q22026-06-3045.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$5.30B

+5.8%

Gross Profit

$2.18B

+9.8%

Gross Margin

41.17%

N/A

Market Cap

$31.82BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$589.17K

N/A

Employees

54,000

N/A

Net Income

$573.00M

+17.9%

EBITDA

$807.00M

-7.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$2.11B

-44.1%

Total Debt

$10.09B

-6.9%

Accounts Receivable

$3.88B

-13.3%

Inventory

$2.48B

+8.8%

Long Term Debt

$10.09B

+17.6%

Short Term Debt

$2.00M

-99.9%

Return on Assets

4.27%

N/A

Return on Invested Capital

8.88%

N/A

Free Cash Flow

-$617.00M

-7812.5%

Operating Cash Flow

-$517.00M

-650.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RMDResMed Inc.
$210.40+0.88%
ALCAlcon Inc.
$68.56-1.51%
ONCBeOne Medicines AG
$315.64-2.00%
MTDMettler-Toledo International Inc.
$1,412.91+2.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
AMZNAmazon
$270.70+0.15%
FCUVFocus Universal
$12.86+5.84%
AAPLApple
$302.33-0.09%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$24.47-0.09%

Questions About GEHC

What is the current price of GE HealthCare Technologies?

GE HealthCare Technologies is trading at $68.31 per share.

What is the 52-week range for GE HealthCare Technologies?

Over the past 52 weeks, GE HealthCare Technologies has traded between $58.75 and $89.77.

How much debt does GE HealthCare Technologies have?

As of the most recent reporting period, GE HealthCare Technologies reported total debt of $10.54B.

How much cash does GE HealthCare Technologies have on hand?

GE HealthCare Technologies reported $2.11B in cash and cash equivalents in its most recent financial results.

What is GE HealthCare Technologies’s dividend yield?

GE HealthCare Technologies currently has a dividend yield of 0.20%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.